Síndrome de Cushing
| dc.contributor.author | Alfaro Zola, Gian Carlo Mauricio | |
| dc.date.accessioned | 2022-12-02T21:45:12Z | |
| dc.date.available | 2022-12-02T21:45:12Z | |
| dc.date.issued | 2022-07-05 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12959/3303 | |
| dc.description.abstract | El síndrome de Cushing se produce como resultado de la exposición crónica al exceso de glucocorticoides, en la mayoría de los casos se debe al consumo de glucocorticoides terapéuticos en dosis altas y en menos proporción a lesiones tumorales hipofisarias. | es_PE |
| dc.format | application/pdf | es_PE |
| dc.language.iso | spa | es_PE |
| dc.publisher | Seguro Social de Salud (EsSalud) | es_PE |
| dc.relation.uri | embed:https://www.youtube.com/embed/BoTLWTe_w_E | es_PE |
| dc.rights | info:eu-repo/semantics/openAccess | es_PE |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | es_PE |
| dc.subject | Síndrome de Cushing | es_PE |
| dc.subject | Adenoma | es_PE |
| dc.subject | Neoplasias hipofisarias | es_PE |
| dc.subject | Hormona adrenocorticotrópica | es_PE |
| dc.title | Síndrome de Cushing | es_PE |
| dc.type | info:pe-repo/semantics/video | es_PE |
| dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.18 | es_PE |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Endocrinología [37]
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
